Acquisition Strengthens Vertex's Position in Immunotherapy and Renal Disease Treatment Vertex Pharmaceuticals (VRTX) and Alpine Immune Sciences, Inc. (Nasdaq: ALPN)...
Peer-Reviewed Article Highlights Safety and Efficacy of Low-Dose Ondansetron in Treating Alcohol Use Disorder Adial Pharmaceuticals (ADIL), a pioneer in...
Early-Stage Trial Signals Potential Breakthrough in Cancer Treatment Moderna (MRNA) witnessed a significant uptick in its shares, climbing 8% to...
Biopharmaceutical Company Raises Capital to Propel Clinical Trials and Innovative Research Acrivon Therapeutics (ACRV), a pioneer in precision oncology medicines,...
Comprehensive Digital Solution Aims to Enhance Patient Outcomes and Clinic Efficiency Allurion Technologies, Inc. has unveiled its Virtual Care Suite...
Acquisition of CAR-NK Assets to Bolster Cancer Therapy Portfolio TC BioPharm (TCBP), a leading biotechnology company specializing in allogeneic gamma-delta...
Updated Interim Results Show Prolonged Survival and Immune Activation in Borderline Resectable PDAC Patients Candel Therapeutics (CADL), a clinical-stage biopharmaceutical...
Vanda Pharmaceuticals Expands Fanapt Franchise with Novel Indication Vanda Pharmaceuticals (VNDA) has announced a significant milestone as the U.S. Food...
Combined Entity Aims to Revolutionize Chronic Skin Disease Treatment with Cutting-Edge Antibodies ARCA biopharma (ABIO) and Oruka Therapeutics have finalized...
Strategic Reprioritization and Partnership with Gilead Sciences Propel Xilio's Innovative Oncology Pipeline Xilio Therapeutics (XLO), a leading biotechnology firm specializing...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?